• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, October 29, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Single phosphorylation event controls where NMDA receptors sit in the brain

by
October 28, 2026
in Health
Reading Time: 2 mins read
0
Single phosphorylation event controls where NMDA receptors sit in the brain

Single phosphorylation event controls where NMDA receptors sit in the brain

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Synapses vary enormously in how many NMDA-type glutamate receptors they carry, and those differences shape how neurons compute. A new study published in Nature Neuroscience on 21 October 2026 reports that a single chemical modification, added by the kinase SIK3 to one site on the obligatory NMDA receptor subunit GluN1, acts as a key signal for recruiting these receptors to synapses. The work, from Rui Lu, Wade Morishita, Xiao Han, Paul Temkin, Robert C. Malenka and Thomas C. Südhof, identifies what the authors describe as a central mechanism controlling synaptic NMDA receptor localization.

NMDA receptors are central components of neural computation, yet how synapses set their levels has remained unclear. Using conditional GluN1 knock-in mice that allow monitoring of endogenous NMDA receptors, the researchers identified synaptic complexes containing SIK3 and GluN1. SIK3, a serine–threonine protein kinase, localizes to synapses, where it phosphorylates GluN1 at a single site. That one phosphorylation event, the study finds, controls the recruitment of NMDA receptors to synapses.

The evidence for selectivity is striking. Genetic deletion of SIK3 severely and selectively decreased synaptic GluN1 levels by roughly 60 percent, without altering levels of AMPA-type glutamate receptors and without inducing major transcriptional changes. In other words, the effect was not a general collapse of synaptic machinery or a downstream consequence of altered gene expression, but a specific loss of NMDA receptors from synapses.

Timing experiments reinforced the conclusion. Pharmacological inhibition of SIK3 impaired synaptic NMDA receptor responses within 45 minutes, indicating that the kinase continuously maintains receptor localization rather than only building it during development. Consistently, mutating the SIK3 phosphorylation site on GluN1 inhibited the synaptic recruitment of the receptor, while phosphomimetic and phosphorylation-blocking GluN1 mutations constitutively enhanced or suppressed NMDA receptor levels, respectively, as summarized in the study’s figure descriptions.

The study also connects the mechanism to sleep biology. ‘Sleepy’, a known gain-of-function mutation in SIK3 that increases sleep, selectively enhanced synaptic NMDA receptor levels by increasing GluN1 phosphorylation. In cultured neurons, the Sleepy mutation selectively increased GluN1 phosphorylation, and in vivo it enhanced synaptic NMDA receptor responses, according to the reported figures. The authors conclude that SIK3 phosphorylation of GluN1 provides a key signal for recruiting NMDA receptors to synapses.

Because the findings are reported in an abstract and figure summaries of a subscription article, they should be read as the authors’ own characterization of their experiments in mice and cultured neurons rather than as independently replicated results. Even so, the work offers a concrete molecular handle on a long-standing question: how individual synapses decide how many NMDA receptors to hold, a decision with broad implications for excitatory signaling in the brain.

Subject of Research: Molecular control of synaptic NMDA receptor localization by SIK3-mediated phosphorylation of GluN1

Article Title: SIK3 controls synaptic localization of NMDA receptors by phosphorylating GluN1

Article References: Lu, R., Morishita, W., Han, X., Temkin, P., Malenka, R. C., & Südhof, T. C. (2026). SIK3 controls synaptic localization of NMDA receptors by phosphorylating GluN1. Nature Neuroscience. https://doi.org/10.1038/s41593-026-02469-9

Image Credits: AI Generated

DOI: 10.1038/s41593-026-02469-9

Keywords: SIK3, GluN1, NMDA receptors, synapse, phosphorylation, glutamate receptors, neuroscience, Sleepy mutation, AMPAR, synaptic localization, controls, synaptic

News Source: Cassandra Pierce. (October 28, 2026). Single phosphorylation event controls where NMDA receptors sit in the brain. Scienmag.

Tags: AMPARcontrolsGluN1glutamate receptorsNeuroscienceNMDA receptorsphosphorylationSIK3Sleepy mutationsynapsesynapticsynaptic localization
Share12Tweet7Share2ShareShareShare1

Related Posts

AI Framework Mines Traditional Chinese Medicine for Phenotype-Based Drug Discovery

AI Framework Mines Traditional Chinese Medicine for Phenotype-Based Drug Discovery

October 29, 2026
Implant Infections After Bone Nailing Hit 8.5% in Ethiopian Tertiary Hospital

Implant Infections After Bone Nailing Hit 8.5% in Ethiopian Tertiary Hospital

October 29, 2026

Adherence, Urban Life and Mood Tied to Remission in Rheumatoid Arthritis Cohort

October 29, 2026

Why Long COVID Fails to Register as a Security Threat

October 29, 2026

POPULAR NEWS

  • Terbium-161 Shows Dose-Dependent Edge Over Lutetium-177 in Mouse Neuroendocrine Tumor Model

    Terbium-161 Shows Dose-Dependent Edge Over Lutetium-177 in Mouse Neuroendocrine Tumor Model

    29 shares
    Share 12 Tweet 7
  • Gas Drainage Lags Pressure Relief by 151.6 Metres in Deep Protective Seam Mining

    29 shares
    Share 12 Tweet 7
  • African Wild Lettuce Shows Anticancer Activity in Lab Studies, Review Finds

    29 shares
    Share 12 Tweet 7
  • SLC7A5 emerges as a central player in cancer amino acid metabolism

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

AI Framework Mines Traditional Chinese Medicine for Phenotype-Based Drug Discovery

New RP-HPLC Method Simultaneously Measures Three Drugs in Combination Inhalers

Realistic Vegan Leather Wins Shoppers, but Lifelike Vegan Fur Backfires in Handbag Ads

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.